Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.71M Buy
9,329
+7,054
+310% +$1.3M 0.02% 225
2025
Q4
$400K Sell
2,275
-19,886
-90% -$3.25M 0.01% 315
2025
Q3
$3.1M Buy
22,161
+15,309
+223% +$2.07M 0.05% 187
2025
Q2
$861K Buy
6,852
+2,006
+41% +$250K 0.02% 237
2025
Q1
$663K Buy
+4,846
New +$693K 0.02% 246
2024
Q4
Sell
-1,411
Closed -$274K 299
2024
Q3
$274K Buy
1,411
+135
+11% +$28.2K 0.01% 270
2024
Q2
$296K Sell
1,276
-188
-13% -$40.9K 0.01% 263
2024
Q1
$316K Sell
1,464
-99
-6% -$23.2K 0.01% 269
2023
Q4
$404K Sell
1,563
-141
-8% -$34.6K 0.02% 244
2023
Q3
$438K Buy
1,704
+80
+5% +$21.4K 0.02% 223
2023
Q2
$463K Sell
1,624
-2,348
-59% -$699K 0.02% 254
2023
Q1
$1.1M Sell
3,972
-200
-5% -$55.3K 0.06% 143
2022
Q4
$1.16M Buy
4,172
+3,452
+479% +$975K 0.07% 120
2022
Q3
$192K Sell
720
-5,580
-89% -$1.19M 0.01% 297
2022
Q2
$1.28M Buy
6,300
+4,103
+187% +$839K 0.07% 123
2022
Q1
$463K Buy
2,197
+652
+42% +$142K 0.02% 245
2021
Q4
$371K Sell
1,545
-118
-7% -$30.3K 0.02% 207
2021
Q3
$471K Buy
1,663
+614
+59% +$201K 0.03% 177
2021
Q2
$340K Buy
+1,049
New +$318K 0.02% 167
2021
Q1
Sell
-2,040
Closed -$537K 180
2020
Q4
$537K Buy
+2,040
New +$526K 0.06% 114

Other funds holding BIIB

AIA Group's BIIB Position: Q1 2026 in Review

AIA Group increased its Biogen (BIIB) stake by 310% in Q1 2026, buying an estimated $1.3M and bringing the position to 9,329 shares worth $1.71M. The position accounts for 0.02% of the portfolio, ranked #225.

AIA Group first reported a position in BIIB in Q4 2020 and has held it in 20 quarters since. The position peaked at $3.1M in Q3 2025. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • AIA Group held 9,329 shares of Biogen worth $1.71M as of Q1 2026.
  • AIA Group bought 7,054 Biogen shares in Q1 2026, an estimated $1.3M.
  • Biogen made up 0.02% of AIA Group's portfolio in Q1 2026, its #225 holding.
  • AIA Group first reported a position in Biogen in Q4 2020 and has held it in 20 quarters since.
  • AIA Group's Biogen position peaked at $3.1M in Q3 2025.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.